“Companies that market and sell these products continue to see their profits grow and more products enter the market. According to a Pew Trust report from January of 2021, more than 40 non-invasive prenatal tests are now available on the market,” the members of Congress said.
“Unfortunately, many of the test manufacturers do not publish data on the accuracy of their tests, and others point to less than satisfactory studies to support their products.”
On Jan. 1, the New York Times published the results of their investigations into the tests.
The Times interviewed researchers and combined studies “to produce the best estimates available of how well the five most common microdeletion tests perform”: DiGeorge syndrome, 1p36 deletion, Cri-du-chat syndrome, Wolf-Hirschhorn syndrome, and Prader-Willi and Angelman syndromes.
The tests’ positive results are wrong around 85% of the time, the Times found. Many women are pressured or moved to consider abortion after a test comes back positive.
“While these tests can help parents prepare for the arrival of their child, we are concerned that they could be a predatory financial windfall for manufacturers and directly result in the termination of innocent human life,” said the letter.
Credit: Source link
